Literature DB >> 16533258

Use of fast fourier transform analysis of atrial electrograms for rapid characterization of atrial activation-implications for delineating possible mechanisms of atrial tachyarrhythmias.

Kyungmoo Ryu1, Jayakumar Sahadevan, Celeen M Khrestian, Bruce S Stambler, Albert L Waldo.   

Abstract

INTRODUCTION: Different analysis techniques have been developed to help understand and characterize the mechanisms responsible for atrial arrhythmias. We tested the hypothesis that Fast Fourier Transform (FFT) analysis of recorded atrial electrograms (AEGs) will rapidly and accurately identify regular and irregular patterns of atrial activation, and, thereby, may provide evidence suggestive of underlying mechanisms of atrial tachyarrhythmias. METHODS AND
RESULTS: During induced atrial tachyarrhythmias in both the canine sterile pericarditis model and canine rapid ventricular pacing-induced congestive heart failure model; 380-404 AEGs were recorded simultaneously from epicardial electrodes on both atria. From AEGs, atrial activation sequences were determined during atrial flutter (AFL), focal atrial tachycardia (AT), and atrial fibrillation (AF). Four-second recording segments of each AEG were subjected to FFT analysis. Frequencies found during FFT analyses in all studies precisely corresponded to the cycle lengths of the AEGs. In AFL and AT, one dominant frequency peak was found throughout both atria. In AF due to multiple unstable reentry circuits, multiple and broad frequency peaks were found in both atria. In AF due to a stable rapid rhythm (driver) in the left atrium with fibrillatory conduction to the rest of the atria, one dominant frequency peak in areas with 1:1 conduction from the driver, and multiple and/or broad frequency peaks in areas with fibrillatory conduction produced by the driver were found. Computation time for all FFT analyses took <5 minutes.
CONCLUSION: FFT analysis accurately and rapidly identifies global atrial activation patterns during AFL, AT, and AF, thereby assisting in determining arrhythmia mechanisms.

Entities:  

Mesh:

Year:  2006        PMID: 16533258     DOI: 10.1111/j.1540-8167.2005.00320.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

1.  Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling.

Authors:  Thomas H Everett; Emily E Wilson; Sander Verheule; Jose M Guerra; Scott Foreman; Jeffrey E Olgin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-07-28       Impact factor: 4.733

2.  Rotor meandering contributes to irregularity in electrograms during atrial fibrillation.

Authors:  Sharon Zlochiver; Masatoshi Yamazaki; Jérôme Kalifa; Omer Berenfeld
Journal:  Heart Rhythm       Date:  2008-03-14       Impact factor: 6.343

Review 3.  Frequency domain mapping of atrial fibrillation - methodology, experimental data and clinical implications.

Authors:  Vassil B Traykov; Robert Pap; Laszlo Saghy
Journal:  Curr Cardiol Rev       Date:  2012-08

Review 4.  Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology.

Authors:  Dobromir Dobrev; Stanley Nattel; Jordi Heijman; Roddy Hiram; Na Li
Journal:  Nat Rev Cardiol       Date:  2022-09-15       Impact factor: 49.421

5.  A three-dimensional human atrial model with fiber orientation. Electrograms and arrhythmic activation patterns relationship.

Authors:  Catalina Tobón; Carlos A Ruiz-Villa; Elvio Heidenreich; Lucia Romero; Fernando Hornero; Javier Saiz
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

6.  The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation.

Authors:  Catalina Tobón; Laura C Palacio; Bojjibabu Chidipi; Diana P Slough; Thanh Tran; Nhi Tran; Michelle Reiser; Yu-Shan Lin; Bengt Herweg; Dany Sayad; Javier Saiz; Sami Noujaim
Journal:  Front Pharmacol       Date:  2019-11-27       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.